SPINK1 and neoplasm: Specifically, the overexpression of SPINK1 in the samples suggested the possibility of a hot tumor, in which effector T cells may play the central part in the antitumor response; therefore, patients with a hot TIME are more likely to respond to immunotherapy (40).